BioProcess International Europe is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Paula Alves is the CEO of iBET, the Head of the Animal Cell Technology Unit and Professor at the NOVA University (ITQB and FCT). She received her Ph.D. at Biochemical Engineering from the NOVA University of Lisbon in 2001 and her B.S in Biochemistry from the Sciences Faculty of the University of Lisbon in 1991. Professor Alves research group integrates cell metabolism understanding with biochemical engineering for the improvement of bioprocesses efficiency and is also focused at developing new tools and technologies for pre-clinical research. The Unit she coordinates uses Animal Cell Technology for research and development in particular for (i) production of complex biopharmaceuticals such as viral vectors, vaccines and recombinant proteins (ii) development of 3D culture systems for toxicity testing using primary cells and stem cells in bioreactors (iii) expand systems biology approaches to organize the complexity of the processes involved in the research described in (i) and (ii). She is currently the President of the ESACT, the European Society for Animal Cell Technology and Member of the Advisory Group for Horizon 2020 Societal Challenge 1 - European Commission. Paula Alves has published over 220 papers, 32 book chapters and supervised 29 PhD students and 10 post-doc.